Cleared Traditional

K193632 - LassoStar Circular Mapping Catheter

K193632 is the FDA 510(k) clearance for LassoStar Circular Mapping Catheter by Biosense Webster, Inc.. It is a Class 2 Cardiovascular device (product code DRF) cleared through the Traditional 510(k) pathway after a 186-day FDA review.

K193632 · Biosense Webster, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2020
Decision
186d
Days
Class 2
Risk

K193632 is an FDA 510(k) clearance for the LassoStar Circular Mapping Catheter. Classified as Catheter, Electrode Recording, Or Probe, Electrode Recording (product code DRF), Class II - Special Controls.

Submitted by Biosense Webster, Inc. (Irvin, US). The FDA issued a Cleared decision on June 30, 2020 after a review of 186 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1220 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Biosense Webster, Inc. devices

Submission Details

510(k) Number K193632 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 27, 2019
Decision Date June 30, 2020
Days to Decision 186 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
61d slower than avg
Panel avg: 125d · This submission: 186d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRF Catheter, Electrode Recording, Or Probe, Electrode Recording
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRF Catheter, Electrode Recording, Or Probe, Electrode Recording

All 96
Devices cleared under the same product code (DRF) and FDA review panel - the closest regulatory comparables to K193632.
Blazer™ Dx-20 Bidirectional Steerable Diagnostic Catheter
K211375 · Boston Scientific Corporation · Sep 2021
MultiCath, AcQRate Dx Fixed Curve Catheter
K201445 · Biotronik, Inc. · Sep 2021
Reprocessed Inquiry Steerable Diagnostic EP Catheter
K203261 · Innovative Health, LLC · Mar 2021
Reprocessed Achieve Advance Mapping Diagnostic Electrophysiology Catheter
K191880 · Innovative Health, LLC · Dec 2019
IntellaMap Orion High Resolution Mapping Catheter
K192360 · Boston Scientific Corporation · Oct 2019
Advisor VL Circular Mapping Catheter, Sensor Enabled
K192037 · Abbott Medical · Sep 2019